Can an effective SARS-CoV-2 vaccine be developed for the older population?
G Pawelec, N Weng - Immunity & Ageing, 2020 - Springer
The emergence of SARS-CoV-2 and its inordinately rapid spread is posing severe
challenges to the wellbeing of millions of people worldwide, health care systems and the …
challenges to the wellbeing of millions of people worldwide, health care systems and the …
COVID-19 in the elderly people and advances in vaccination approaches
K Dhama, SK Patel, S Natesan, KS Vora… - Human vaccines & …, 2020 - Taylor & Francis
The rapid worldwide spread of the COVID-19 pandemic, caused by the newly emerged
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in tens of …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in tens of …
Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population
The SARS-CoV-2 pandemic urgently calls for the development of effective preventive tools.
COVID-19 hits greatly the elder and more fragile fraction of the population boosting the …
COVID-19 hits greatly the elder and more fragile fraction of the population boosting the …
Covid-19 and immunity in aging populations—a new research agenda
WC Koff, MA Williams - New England Journal of Medicine, 2020 - Mass Medical Soc
Covid-19 and Immunity in Aging Populations As billions of dollars flow into research and
development efforts aimed at controlling SARS-CoV-2, the pandemic response remains …
development efforts aimed at controlling SARS-CoV-2, the pandemic response remains …
The impact of immuno-aging on SARS-CoV-2 vaccine development
The SARS-CoV-2 pandemic has almost 56 million confirmed cases resulting in over 1.3
million deaths as of November 2020. This infection has proved more deadly to older adults …
million deaths as of November 2020. This infection has proved more deadly to older adults …
Aging in COVID-19: Vulnerability, immunity and intervention
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic was first
reported in Wuhan, China in December 2019, moved across the globe at an unprecedented …
reported in Wuhan, China in December 2019, moved across the globe at an unprecedented …
Unanticipated efficacy of SARS-CoV-2 vaccination in older adults
G Pawelec, J McElhaney - Immunity & Ageing, 2021 - Springer
The rapidity with which vaccines against COVID-19 have been developed and tested is
unprecedented. As classically the case with randomized clinical trials, many studies …
unprecedented. As classically the case with randomized clinical trials, many studies …
SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes
J Nikolich-Zugich, KS Knox, CT Rios, B Natt… - Geroscience, 2020 - Springer
Abstract SARS-CoV-2 virus, the causative agent of the coronavirus infectious disease-19
(COVID-19), is taking the globe by storm, approaching 500,000 confirmed cases and over …
(COVID-19), is taking the globe by storm, approaching 500,000 confirmed cases and over …
Immune response to COVID-19 in older adults
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the third highly
pathogenic coronavirus to emerge in the human population in last two decades. SARS-CoV …
pathogenic coronavirus to emerge in the human population in last two decades. SARS-CoV …
[HTML][HTML] Are older people really more susceptible to SARS-CoV-2?
S Zhang, Z Yang, ZN Li, ZL Chen, SJ Yue… - Aging and …, 2022 - ncbi.nlm.nih.gov
Since the outbreak, COVID-19 has spread rapidly across the globe due to its high infectivity
and lethality. Age appears to be one of the key factors influencing the status and progression …
and lethality. Age appears to be one of the key factors influencing the status and progression …